Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARQ-154 foam versus vehicle in adolescents and adults with scalp and body plaque psoriasis
2019-003354-92Phase 2Completed
- Sponsor
- Arcutis Biotherapeutics
- Start
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, double-blind trial of roflumilast in plaque psoriasis and psoriasis (2 arms), sponsored by Arcutis Biotherapeutics. Primary endpoint: S-IGA Success at Week 8. Started Jan 2020; status: completed.
02
Drugs
roflumilast
03
Conditions
plaque psoriasispsoriasis
Beyond the preview
Go deeper on 2019-003354-92.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-003354-92.